Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Items 901–1,000 of 1,002
Flores‐Constante, G., Sánchez‐Chávez, A. C., & Polindara‐García, L. A. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800756 · Cited by 12
Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis
Satiya, J., Snyder, H. S., Singh, S. P., & Satapathy, S. K. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-20-247 · Cited by 12
Mawardi, M., Alalwan, A. M., Fallatah, H. I., Abaalkhail, F. A., Hasosah, M. Y., Shagrani, M. A., Alghamdi, M., & Alghamdi, A. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_112_21 · Cited by 14
“[56] In comparison to chenodeoxycholic acid, FXR is effectively activated by OCA.”
BackgroundHao, Y., Zhou, P., Zhu, Y., Zou, S., Zhao, Q., Yu, J., Hu, Y., & Li, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.853566 · Cited by 15
“A number of bile-acid-activated signaling pathways were selected as crucial therapeutic targets for metabolic disorders (Thomas et al., 2008).”
BackgroundZhu, X., Xia, E.-Q., Liu, Y., Wei-Qiao, L. I., Yan, X. I. N., Lin, X., Marozik, P. M., & Guo, H. (2022) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2022.100175 · Cited by 12
The role of human milk fats in shaping neonatal development and the early life gut microbiota
Seki, D., Errerd, T., & Hall, L. J. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.09 · Cited by 15
Poša, M., Rašeta, M. J., & Kuhajda, K. (2010) · Hemijska industrija · doi:10.2298/hemind100924071p · Cited by 12
“[4].”
Discovering Networks of Perturbed Biological Processes in Hepatocyte Cultures
Lasher, C. D., Rajagopalan, P., & Murali, T. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015247 · Cited by 12
“Subsequently, the liver re-mobilizes these fatty acids throughout the body via lipoproteins [34].”
BackgroundThe impact of cholesterol and its metabolites on drug metabolism
Režen, T. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.558083 · Cited by 14
“However, increasing amount of data indicate that bile acids are involved also in regulation of cholesterol, glucose, triglyceride and energy metabolism [1,2].”
BackgroundDopico, A. M., & Bukiya, A. N. (2017) · Current topics in membranes · doi:10.1016/bs.ctm.2017.07.001 · Cited by 13
Research progress on signaling pathways in cirrhotic portal hypertension
Xu, W., Liu, P., & Mu, Y. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i10.335 · Cited by 14
Chen, X., Liao, D., Qin, Z., & Li, X. (2018) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2018.05.006 · Cited by 12
Ravacci, G. R., Ishida, R. K., Torrinhas, R. S., Sala, P., Machado, N. M., Fonseca, D. C., Canuto, G. A. B., Pinto, E., Nascimento, V., Tavares, M. F. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42082-4 · Cited by 16
Rizki-Safitri, A., Shinohara, M., Tanaka, M., & Sakai, Y. (2020) · Journal of Biological Engineering · doi:10.1186/s13036-020-0230-z · Cited by 13
Wu, J., Fang, S., Li, W., Li, Y., Li, Y., Wang, T., Yang, L., Liu, S., Wang, Z., & Ma, Y. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122269 · Cited by 12
Divergence in aerobic capacity impacts bile acid metabolism in young women
Maurer, A., Ward, J. L., Dean, K. M., Billinger, S. A., Lin, H., Mercer, K. E., Adams, S. H., & Thyfault, J. P. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00577.2020 · Cited by 14
Cellular mechanism of bile acid-accelerated hepatocyte polarity
Fu, D., Lippincott‐Schwartz, J., & Arias, I. M. (2011) · Small GTPases · doi:10.4161/sgtp.18087 · Cited by 14
“Approximately 85% of bile acids are absorbed and transported back to the liver via the enterohepatic circulation.(10) The traditional function of bile acids is to emulsify dietary fat;(11) however, bile acids are also signaling molecules,(12,13) which are involved in many signaling pathways including increasing cellul…”
Zhao, X., Li, R., Sun, R., Pan, Q., Lu, H., & Chai, J. (2025) · EngMedicine · doi:10.1016/j.engmed.2025.100088 · Cited by 14
In vitro models to detect in vivo bile acid changes induced by antibiotics
Zhang, N., Wang, J., Bakker, W., Zheng, W., Baccaro, M., Murali, A., van Ravenzwaay, B., & Rietjens, I. M. C. M. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03373-4 · Cited by 12
“Additionally, bile acids are important signaling molecules that are able to modulate lipid, glucose, and energy metabolism by reacting with diverse bile acid receptors (Houten et al. 2006; Thomas et al. 2008).”
BackgroundChronic corticosterone exposure disrupts hepatic and intestinal bile acid metabolism in chicken
Wu, L., Liu, X., Zhang, A., Chen, H., Zhao, R., & Jia, Y. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1147024 · Cited by 13
“In addition, BA is also a signal molecule binding to nuclear receptors in the liver and intestine, farnesoid X receptor (FXR), and Takeda G protein-coupled receptor 5 (TGR5) to regulate lipid metabolism (8, 9).”
BackgroundXiong, H., Chen, H., Chen, L., Ouyang, K., Lin, S., & Wang, W. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250078 · Cited by 11
“Extensive studies have shown that BAs modulate intestinal inflammation through binding to receptors [134].”
Li, Y., Wang, H., He, X., Zhu, W., Bao, Y., Gao, X., Huang, W., Ge, X., Wei, W., Zhang, H., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01021-w · Cited by 14
“Bile acids (BAs) are among the main constituents of bile, which contribute to the dissolution and digestion of the dietary lipids [5].”
BackgroundKumar, D., & Poša, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313055 · Cited by 11
Liu, J., Guo, M., Yuan, X., Fan, X., Wang, J., & Jiao, X. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70068 · Cited by 13
“Bile acids (BAs) refer to a large group of cholic acids that exist in the form of sodium or potassium salts in bile [109].”
Shen, W.-X., Li, Z., Wang, L., Liu, Q., Zhang, R., Yao, Y., Zhao, Z., & Ji, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-99973-y · Cited by 13
“One study showed that MSTN gene mutation up-regulates hepatic bile acid synthesis and regulates bile acid metabolism 27 .”
Zhang, X., Sheng, N., Wang, Z., Cao, Y., Jiang, X., Yan, H., Cheng, F.-F., Geng, T., Wei, K., Zhang, L., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120124 · Cited by 11
Gomez-Perez, A., Kyryakov, P., Burstein, M. T., Asbah, N., Noohi, F., Iouk, T., & Titorenko, V. I. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00216 · Cited by 11
“…fat-soluble vitamins, affect the composition and proliferation of the intestinal microbial flora, and support the maintenance of organismal sterol homeostasis (Thomas et al., 2008; Amaral et al., 2009; Hylemon et al., 2009; Lefebvre et al., 2009; Monte et al., 2009; de Aguiar Vallim et al., 2013).”
BackgroundInfluentialJönsson, T. J., Schäfer, H., Herling, A. W., & Brönstrup, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207210 · Cited by 10
Garcia, M., Thirouard, L., Monrose, M., Holota, H., Haze, A. D., Caira, F., Beaudoin, C., & Volle, D. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03247-6 · Cited by 12
The Function of Xenobiotic Receptors in Metabolic Diseases
Zhang, J., Jia, Q., Li, Y., & He, J. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000862 · Cited by 11
“Bile acids are being increasingly investigated as complex metabolic integrators and signaling factors and not just as lipid solubilizers but also as simple modulators of bile acid homeostasis(Thomas et al., 2008).”
BackgroundLiu, H., Yokoyama, F., & Ishizuka, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159319 · Cited by 13
Kim, W. J., Ryu, R., Doo, E., Choi, Y., Kim, K., Kim, B. K., Kim, H., Kim, M., & Huh, C. S. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10156-5 · Cited by 14
“Gut microbiota produces various bacterial metabolites, such as short-chain fatty acids [23], indole [24], and secondary bile acids [25], which affect host energy absorption and expenditure [26, 27].”
Poša, M., & Sebenji, A. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.12.030 · Cited by 11
Zhang, J., Li, H., Zhou, H., Fang, L., Xu, J., Yan, H., Chen, S., Song, Q., Zhang, Y., Xu, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06252-6 · Cited by 13
THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN THE PATHOGENESIS OF HYPERLIPIDEMIA
Kvit, K. B., Kharchenko, N. V., Kharchenko, V. V., Chornenka, O. I., Chornovus, R. I., Dorofeeva, U. S., Draganchuk, O. B., & Slaba, O. M. (2019) · Wiadomości Lekarskie · doi:10.36740/wlek201904127 · Cited by 17
“It should also be noted that deconjugated bile acids are rapidly absorbed, which prematurely turns them off from digestion processes [9,10].”
BackgroundZipori, Y., Bachar, G., Farago, N., Lauterbach, R., Weissman, A., Beloosesky, R., & Weiner, Z. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.08.043 · Cited by 11
Yang, C., Brecht, J., Weiß, C., Reißfelder, C., Otto, M., Buchwald, J. N., & Vassilev, G. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05677-3 · Cited by 13
“The classic pathway is responsible for 75% of BA pool size and is regulated by the rate-limiting enzyme, cholesterol 7α-hydroxylase (CYP7A1) [12, 13].”
BackgroundBrønden, A., Hansen, M., Sonne, D. P., Rohde, U., Vilsbøll, T., & Knop, F. K. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12355 · Cited by 12
“In addition, bile acids are signalling molecules with classical endocrine properties and work as complex metabolic integrators modulating lipid and glucose metabolism [3].”
BackgroundFeng, X., Du, X., Chen, S., Yue, D., Cheng, Y., Zhang, L., Gao, Y., Li, S., Chen, L., Peng, Z., et al. (2015) · Europe PMC (PubMed Central) · Cited by 11
Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes
Zhang, X., Wall, M., Sui, Z., Kauffman, J. A., Hou, C., Chen, C., Du, F., Kirchner, T., Liang, Y. T., Johnson, D. L., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00116 · Cited by 11
Do Therapeutic Bile Acids Hit the Sweet Spot of Glucose Metabolism in NAFLD?
Karpen, S. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.017 · Cited by 12
Shen, B., Zhou, C., Gu, T., Shen, Z., Guo, Y., Dai, W., Liu, Y., Zhang, J., Lu, L., & Dong, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1080226 · Cited by 13
“Notably, the classical pathway accounts for approximately 75% of BA synthesis (Thomas et al., 2008).”
BackgroundGuo, X., Zhou, Q., Jin, J., Lan, F., Wen, C., Li, J., Yang, N., & Sun, C. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00910-8 · Cited by 11
“Bile acids have a positive effect on lipid metabolism, emulsifying fats, promoting the hydrolysis activity of lipase and lipoprotein esterase on fat, and transporting fats in the intestine to promote fat absorption [4].”
BackgroundThe role of the gut microbial metabolism of sterols and bile acids in human health
Tang, J., Xu, W., Yu, Y., Yin, S., Ye, B.-C., & Zhou, Y. (2024) · Biochimie · doi:10.1016/j.biochi.2024.11.003 · Cited by 12
Koh, Y., Ch, L., Leung, S.-Y., Lin, W., Ho, P.-Y., Ho, C., & Pan, M. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c00255 · Cited by 11
Zhou, Z., Xu, D., Huang, L., Cui, Y., Chen, H., & Tang, J. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70155 · Cited by 10
“Nowadays, bile acid has become increasingly known as a pivotal signaling factor and metabolism ‐ regulating factor [4], and numerous pathological processes have been confirmed to involve bile acid metabolism misregulation [5].”
Wang, Y., Deng, D., Mai, M., Song, W., Yuan, Q., Xie, Y., Mo, B., & Guo, H. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106812 · Cited by 11
Chen, J., Zhang, L., Chen, Y., Yan, Y., & Lu, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157108 · Cited by 10
Guan, Y., Xu, F., Zhang, X., Fu, X., Wang, J., Song, S., Sun, Y., Yuan, Q.-Y., & Zhu, F. (2022) · Metabolomics · doi:10.1007/s11306-022-01906-7 · Cited by 11
“Several bile-related disorders can induce the occurrence of diseases, including obesity, type 2 diabetes, and atherosclerosis (Thomas et al., 2008), but the most common disease is cholelithiasis affecting 10% of the population (Tazuma, 2006).”
BackgroundZhan, X., He, M., Pei, J., Fan, W., Mwangi, C. N., Zhang, P., Chai, X., & Jiang, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.850777 · Cited by 10
Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming
Chen, H., Li, L., & Du, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1115226 · Cited by 14
“BAs play an important role not only in promoting the intestinal absorption and transport of lipids and nutrients, but also in acting as a complex molecular signaling system (Thomas et al., 2008; McGlone and Bloom, 2019; Collins et al., 2022).”
BackgroundManagement of Metabolic-Associated Fatty Liver Disease
Venkatesan, K., & Haroon, N. N. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.02.002 · Cited by 11
Vivian, D., Cheng, K., Khurana, S., Xu, S., Whiterock, V. J., Witter, D., Lentz, K. A., Santone, K. S., Raufman, J., & Polli, J. E. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0963-6 · Cited by 10
“Bile acids are amongst the most “handled” compounds in the body, reflecting their important roles in lipid digestion and the regulation of key physiological processes such as energy balance (27), glucose metabolism (28), bile acid synthesis (29) and cholesterol metabolism (30).”
BackgroundAn association between post-meal bile acid response and bone resorption in normal subjects
Ewang-Emukowhate, M., Alaghband-Zadeh, J., Vincent, R. P., Sherwood, R., & Cf, M. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213482891 · Cited by 10
“They act as signalling molecules to peripheral tissues informing them about meal intake and energy availability.(13) These effects are mediated via the TGR5 receptor.”
BackgroundZabala‐Letona, A., Niot, I., Laugerette, F., Athias, A., Monnot, M.-C., Portillo, M. P., Besnard, P., & Poirier, H. (2011) · Journal of Nutrition · doi:10.3945/jn.110.136168 · Cited by 10
“Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, et al. TGR5-mediated bile acid sensing controls glucose homeostasis.”
BackgroundInfluentialPoša, M., Bjedov, S., Tepavčević, V., Mikulić, M., & Sakač, M. N. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.112634 · Cited by 10
Fang, M., Qi, Z., Yu, P., Ge, C., Guo, J., Zhang, Y., & Wang, H. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.06.011 · Cited by 10
Sendensky, A., & Dufour, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_2 · Cited by 10
Zheng, J., Peng, X., Zhu, T., Huang, S., Chen, C., Chen, G., Liu, S., & Ouyang, G. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463634 · Cited by 11
Xu, Y., Zhang, Y., Tao, Q., Sun, Q., Zheng, Y., Yin, D., & Yang, Y. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138209 · Cited by 10
Transcription Factors Potentially Involved in Regulation of Cytochrome P450 Gene Expression
Czekaj, P., & Skowronek, R. (2012) · InTech eBooks · doi:10.5772/27817 · Cited by 12
“Lack of LXR inhibits conversion of cholesterol into bile acids (Thomas et al., 2008; Wagner et al., 2011).”
BackgroundMatysik, S., Orsó, E., Black, A., Ahrens, N., & Schmitz, G. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.05.001 · Cited by 14
“…xanthomatosis (CTX) is a rare, inherited utosomal-recessive lipid-storage disorder of abnormal side-chain odification of bile acids, due to the loss-of-function mutaions of the mitochondrial sterol 27-hydroxylase gene (CYP27A1) Bjorkhem and Hansson, 2010; Thomas et al., 2008; Sundaram t al., 2008).”
BackgroundHow to modulate FXR activity to treat the Metabolic Syndrome
Prawitt, J., Caron, S., & Staels, B. (2009) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.05.002 · Cited by 10
Fang, N., Yu, S., Adams, S. H., Ronis, M. J. J., & Badger, T. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.d069831 · Cited by 10
“Another species-specific primary BA is ursodeoxycholic acid (UDCA, an isomer of CDCA) in bears (7).”
BackgroundThe role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury
Wen, Y., Zhang, G., & Wu, X. (2022) · Toxicology · doi:10.1016/j.tox.2022.153256 · Cited by 9
Gut microbiome metabolites as key actors in atherosclerosis co-depression disease
Liao, X.-X., Wu, X., Zhou, Y.-L., Li, J., Wen, Y.-L., & Zhou, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988643 · Cited by 10
“The synthesis of bile acids relies on two main pathways: one is initiated by the cholesterol 7α-hydroxylation reaction catalyzed by the rate-limiting enzyme cholesterol 7a-hydroxylase (CYP7A1), which accounts for 75% of the total synthesis (Thomas et al., 2008); and the other is initiated by the catalysis of sterol-27…”
BackgroundTao, D., Dong, Y., Che, D., Wang, Z., Zheng, Y., Han, R., & Jiang, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141467 · Cited by 10
Romeo, M., Dallio, M., Nardo, F. D., Napolitano, C., Vaia, P., Martinelli, G., Federico, P., Olivieri, S., Iodice, P., & Federico, A. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15040124 · Cited by 15
“…and Activator of Transcription (JAK-STAT3), cyclooxygenase-2 (COX-2), and NF-kB], amplifying the polarization of M2-like tumor-associated macrophages (TAM-M2), and enhancing the local production of inflammatory mediators [IL-6, IL-1beta, and TNF-alpha] via activating inflammasome [76,77].”
Altered iso- and oxo-Fecal Bile Acid Concentrations in Dogs with Chronic Enteropathy
Blake, A. B., Toresson, L., Chen, C.-C., Ishii, P. E., Phillips, R. K., Giaretta, P. R., Cavasin, J. P., Lidbury, J. A., & Suchodolski, J. S. (2025) · Pets · doi:10.3390/pets2020018 · Cited by 14
Li, L., Li, J., Liu, Z., Jin, Z., Wang, M., Wu, Y., Zhang, Z., Hou, X., Yao, J., & Zhang, J. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01207-8 · Cited by 11
“Sec-ondly, changes in the abundance and composition of gut microorganisms due to physiological states and diets can also affect the amount and composition of BAs, which in turn play an important role in regulating host cholesterol, TG, glucose levels, and insulin sensitivity [25–27].”
Zhang, P., Xu, S., Li, N., & Yu, C. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09176-8 · Cited by 12
“Among bile acid receptors, farnesoid X receptor, also known as the “nuclear bile acid receptor,” is highly expressed in bile acid-exposed tissues, such as the liver and intestine, and serves as a central regulator of BA metabolism [51, 52].”
Dietary Choices Modulate Colorectal Cancer Stem Cells: A Role of FXR Nuclear Receptor
Sharma, N. K., Sarode, S. C., Sarode, G. S., Patil, S., & Pal, J. K. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1792949 · Cited by 9
Age-Related Metabolic Pathways Changes in Dental Follicles: A Pilot Study
Bastos, V. C., Vitório, J. G., Martins‐Chaves, R. R., Leite‐Lima, F., Lebron, Y. A. R., Moreira, V. R., Duarte‐Andrade, F. F., Pereira, T. D. S. F., Santos, L. V. D. S., Lange, L. C., et al. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.677731 · Cited by 9
“Through activation of signaling pathways triggered by the activation of G-protein-coupled receptors (GPCRs) or nuclear bile acid receptors (including farnesoid-X receptor, FXR, also known as NR1H4), bile acids have been shown to regulate not only their own synthesis and enterohepatic recirculation, but also regulate t…”
BackgroundHuman microbiome and cardiovascular diseases
Alam, J., Puppala, V., Uppulapu, S. K., Das, B., & Banerjee, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.012 · Cited by 11
Global optimization of cholic acid aggregates
Jójárt, B., Viskolcz, B., Poša, M., & Fejer, S. N. (2014) · The Journal of Chemical Physics · doi:10.1063/1.4869832 · Cited by 9
Villar-Lorenzo, A., Ardiles, A., Arroba, A. I., Hernández-Jiménez, E., Pardo, V., López‐Collazo, E., Jiménez, I. A., Bazzocchi, I. L., González‐Rodríguez, Á., & Valverde, Á. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.10.004 · Cited by 9
Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
Agarwal, S., Sasane, S., Kumar, J., Darji, B., Bhayani, H., Soman, S. S., Kulkarni, N. D., & Jain, M. R. (2019) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2019.100002 · Cited by 9
Advantages and Limitations of Cre Mouse Lines Used in Skeletal Research
Elefteriou, F., & Couasnay, G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1028-2_3 · Cited by 9
Cummings, B. P., Graham, J. L., Stanhope, K. L., Chouinard, M. L., & Havel, P. J. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1076-y · Cited by 11
“Bile acids have also been shown to signal through TGR5 receptors located in the distal small intestine to increase GLP-1 secretion and in TGR5 receptors on skeletal muscle and brown adipose tissue to increase energy expenditure [34, 35].”
BackgroundHeinzmann, S. S., & Schmitt‐Kopplin, P. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00034 · Cited by 11
Shyng, S. (2017) · Diabetes · doi:10.2337/dbi16-0066 · Cited by 9
Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma
Deng, M., Liu, J., Zhang, L., Lou, Y., & Qiu, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-13081-0 · Cited by 9
“In addition, recent studies have manifested that bile acids serve as essential molecules in the regulation of intracellular signaling pathways through receptors such as FXR or TGR5 [14–17].”
BackgroundDu, J., Shen, M., Chen, J., Yan, H., Xu, Z., Yang, X., Yang, B., Luo, P., Ding, K., Hu, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1510080 · Cited by 11
Fang, Q., Hou, X., Fan, L., Deng, Y., Li, X., Zhang, H., Wang, H., Fu, Z., Sun, B., Shu, X., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107636 · Cited by 11
Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease
Tang, Y., Zhang, Y., Chen, C., Cao, Y., Wang, Q., & Tang, C. (2025) · Journal of Central Nervous System Disease · doi:10.1177/11795735251322450 · Cited by 10
Bile Acids and Type 2 Diabetes: Roles in Glucose Homeostasis and Therapeutic Opportunities
Lin, Y., Hu, C., Wang, S., & Lin, H. (2025) · Metabolites · doi:10.3390/metabo15060401 · Cited by 10
“Initially, primary conjugated BAs are deconjugated into unconjugated BAs by the activity of bile salt hydrolase (BSH) [26].”
Lü, Y., Feng, X., Wang, Z., Zou, M., Xu, Z., Liu, Q.-J., Chen, W., Ding, J., & Liu, H. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf020 · Cited by 13
Yuan, R., Li, Y., Wang, Y., Li, Q., Guo, C., & Wang, L. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00809-4 · Cited by 8
“Similarly, the S1PR2 receptor agonist CYM5520 could hardly replicate the effects of TCA (Supplementary Fig.”
InfluentialWang, J., Zhang, Y., Wu, Q., Zhong, Y.-F., Xu, Z., & Yang, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1757551 · Cited by 17
Microbial transformation of secondary bile acids: roles in gut ecology and autoimmune diseases
Ren, L., Li, M., Wu, L., Lin, Z. M., & Chen, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1769792 · Cited by 10
“PBAs undergo conjugation with amino acids to enhance their solubility; glycine conjugation predominates in humans, whereas taurine conjugation is the principal form in mice (19).”
Sun, L.-Y., Sun, G.-Y., Nan, Y., Wang, H., Sun, Y., Shi, Y., Yang, Y., & Wang, Q.-F. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1778473 · Cited by 8
“Bile acids absorbed in the intestine return to the liver via the portal vein, forming an efficient recycling system that cycles 6–8 times daily, with only approximately 5% excreted in feces (63).”
Felton, J. M., Cheng, K., Said, A. H., Shang, A. C., Xu, S., Vivian, D., Metry, M., Polli, J. E., & Raufman, J. (2016) · Journal of Visualized Experiments · doi:10.3791/54597 · Cited by 7
Stierwalt, H. D., Morris, E. M., Maurer, A., Apte, U. M., Phillips, K., Li, T., Meers, G. M.-E., Koch, L. G., Britton, S. L., Graf, G., et al. (2022) · Physiological Reports · doi:10.14814/phy2.15405 · Cited by 8
Mio, K., Iida‐Tanaka, N., Togo‐Ohno, M., Tadenuma, N., Yamanaka, C., & Aoe, S. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109547 · Cited by 9
Kanika, N. H., Hou, X., Liu, H., Dong, Y., Wang, J., & Wang, C. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae226 · Cited by 9
Ghaffarzadegan, T., Zanzer, Y. C., Östman, E. M., Hållenius, F. F., Essén, S., Sandahl, M., & NYMAN, M. E. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900672 · Cited by 9
The Influence of Microbiota on Mechanisms of Bariatric Surgery
Floch, N. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00031-8 · Cited by 9
Gitto, S., Guarneri, V., Sartini, A., & Andreoné, P. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1399060 · Cited by 9
“Moreover, FXR activation can determine a decrease of triglyceride levels and VLDL synthesis and a rise of both insulin production and sensitivity [21].”
BackgroundThe Gut Microbiome After Bariatric Surgery
Solar, C., Escalona, A., & Garrido, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00024-5 · Cited by 9
Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis
Caines, A., Trudeau, S., & Gordon, S. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2390120 · Cited by 7
“OCA – a farnesoid X receptor (XR) agonist – was approved in the US in 2016 for use in combination with UDCA or as monotherapy for those intolerant to UDCA [10,11]; however, labeling was revised contraindicating its use in patients with advanced or decompensated cirrhosis [12].”
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.